about
Toward a New Era of Trust and Transparency in Clinical TrialsIs Open Science the Future of Drug Development?Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analysesData Access and Sharing: Are we being transparent about clinical research? Let's do what's right for patients.Transparency and public accessibility of clinical trial information in Croatia: how it affects patient participation in clinical trialsUpdate on Trial Registration 11 Years after the ICMJE Policy Was Established.Examining Provisions Related to Consent in the Revised Common Rule.A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritisEfficient design of clinical trials and epidemiological research: is it possible?Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches.Characteristics and trends of clinical trials funded by the National Institutes of Health between 2005 and 2015.Clinical Trials.Gov: A Topical Analyses.Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis.Time to publication of oncology trials and why some trials are never published.Generic Modified-Release Antiepileptic Drugs: No Difference Within Formulations, but Important Differences Across FormulationsReview and publication of protocol submissions to Trials - what have we learned in 10 years?Alzheimer's disease drug development pipeline: 2017.Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011.Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov.Adherence to guidance on registration of randomised controlled trials published in Anaesthesia.Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.Practical guidance for using multiple data sources in systematic reviews and meta-analyses (with examples from the MUDS study).ClinicalTrials.gov for Facilitating Rapid Understanding of Potential Harms of New Drugs: The Case of Checkpoint Inhibitors.mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancers.Promoting public access to clinical trial protocols: challenges and recommendations.Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2014.Cancer Immunotherapy Trials Underutilize Immune Response Monitoring.Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications.Standards for design and measurement would make clinical research reproducible and usable.Conditional equivalence testing: An alternative remedy for publication bias.Clinical trial registration and reporting: a survey of academic organizations in the United States.Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes.What's New This Year?Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar.Comparing and Contrasting A Priori and A Posteriori Generalizability Assessment of Clinical Trials on Type 2 Diabetes Mellitus.How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider.Sponsorship, conflict of interest, risk of bias, and reporting of participant's flow and baseline demographic information in studies applicable to the federal law to post the results in clinicaltrials.gov.Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.Alzheimer's disease drug development pipeline: 2018.
P2860
Q27205111-F60D936E-580B-40D3-877E-DA70188A34D8Q29237434-ACE46F4A-0D0E-47A6-9872-76886D6BE4F2Q30235881-6D3CFACE-72D1-4E29-80B9-21C589F7B28CQ30491337-EA9B2633-1F41-41F0-ACD8-0ACDEE69F783Q33859342-0CA634D0-6CDF-43A0-8658-D6E7B004D6EEQ36259583-30842676-3199-484E-9BB1-D6AB535AA2B3Q38665107-906873E9-C548-415A-8860-6DBA7F2D7F87Q38780115-0B2FA1F5-620B-4892-8934-AFEC76E195FDQ38817527-88833913-F591-4AEC-8AE5-315264EF7336Q38904292-DF363472-B49E-42BC-9163-A0B7DE40DA46Q40054181-1F749741-8505-43F2-8E1F-831439F346F4Q41246114-1DB191C2-EEF6-4DA9-98B9-47A1BAE77B8EQ41503758-3B7FA1F2-D621-4E90-931C-0B7E46121EDFQ41886616-C251B08C-6071-4682-B5F5-65013AD9C698Q42317851-65A25D24-72D6-44E9-AE69-3E6AA2B126C8Q42328582-7BE71102-52CD-49B5-BE92-54450F76802BQ42655757-97F7B90F-61B5-455D-ABCB-DB01EF30878BQ44874879-47206F38-F96F-4FC4-9418-31BCD4F6B991Q46177929-5EF526EC-9567-4AED-8B3C-A477A43494E4Q47103652-BEFAD811-C6A3-4BCB-AB5C-7547EDC6C6FDQ47216080-7BA5EA81-2D16-4648-B902-4553C738B287Q47717067-76F2B050-10C6-4EF2-BAD9-3AC3C2F9DEA4Q47745738-41E1C605-534D-41C7-A367-6DE46686DAA9Q49342746-ED9A9BE4-E73F-481F-9D44-174CF21BA6C0Q49446450-F4FDB61C-AE17-4BF7-8038-06D408C26644Q49900242-9FB86B4B-CCF3-4963-9519-E9A0C9C85D82Q50010648-47556889-37E0-466D-BE20-C6288130EA7BQ50082770-905A936B-16D1-4E3D-94ED-7D186EF72B8CQ50158790-CF0C762C-0414-4E10-8D1F-004733A4F6C7Q52659602-733F7439-3376-423B-804F-DC157544EFE4Q53279722-BAA35976-C0AD-47CD-B2F4-1E61B18C50D7Q53282847-8B9BAC5D-537B-4756-83A6-09E59FEB202CQ53341930-A09D1EED-7177-4878-AD01-2AA326E541BAQ53589839-DCE2A9DC-CD6F-486E-A3E3-4F70CA354505Q54967381-8E12D502-53F1-4D15-817A-209E69B79D9BQ55008615-D47FE3C2-51FB-49A6-8695-9207DC273024Q55009838-24E87EAB-9482-459F-837F-DB95E61B0489Q55081974-D436818C-000D-4F8E-9055-60C604A36D37Q55190272-C72A2143-307B-47C4-A4B3-C03DF300ADF6Q55357444-EBBB5A78-8F3D-465F-B03E-0A6BD899C137
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Trial Reporting in ClinicalTrials.gov - The Final Rule
@ast
Trial Reporting in ClinicalTrials.gov - The Final Rule
@en
type
label
Trial Reporting in ClinicalTrials.gov - The Final Rule
@ast
Trial Reporting in ClinicalTrials.gov - The Final Rule
@en
prefLabel
Trial Reporting in ClinicalTrials.gov - The Final Rule
@ast
Trial Reporting in ClinicalTrials.gov - The Final Rule
@en
P2093
P2860
P356
P1476
Trial Reporting in ClinicalTrials.gov - The Final Rule
@en
P2093
Rebecca J Williams
Sarah Carr
P2860
P304
P356
10.1056/NEJMSR1611785
P407
P577
2016-09-16T00:00:00Z